Hope in the Pipeline
Hope in the Pipeline
Podcast Description
Tomorrow’s Medicine, Today’s Breakthroughs at Preferred Research Partners hosted by Dr. Paul E. Wylie.
Podcast Insights
Content Themes
The podcast focuses on topics related to mental health, particularly social anxiety and the use of psychedelics in treatment. Episodes include detailed discussions on the symptoms and treatment options for anxiety disorders, as well as the innovative use of psychedelics for addressing mood disorders and promoting neuroplasticity. Specific episodes highlight clinical trials and the evolving landscape of psychiatric treatments.
Tomorrow’s Medicine, Today’s Breakthroughs at Preferred Research Partners hosted by Dr. Paul E. Wylie.
Millions of workers rely on shift work to keep essential services running, but at what cost? Dr. Paul Wylie, a Neuropsychiatry and Sleep Medicine Specialist, dives into Shift Work Sleep Disorder (SWSD)—its impact on sleep, productivity, and long-term health risks like mood disorders, diabetes, and even cancer.
Preferred Research Partners is currently enrolling participants for a 12-week clinical trial testing a medication that may improve alertness, cognitive function, and workplace safety for shift workers.
📞 501-553-9987
🌐 www.PreferredResearchPartners.com
If you or someone you know struggles with shift work-related sleep issues, watch, share, and subscribe for more sleep health insights.
#ShiftWork#SWSD#SleepDisorder#NightShift#CircadianRhythm#SleepOptimization#WorkLifeBalance#psychadelics#mentalhealth#mentalhealthawareness
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.